Apollo-Amrish Oncology Services Private Limited - Due diligence report

A 360° intelligence report on Apollo Cbcc Cancer Care: trust score, financial health, credit view, compliance, directors, growth and distres…

2014-07-01 Chennai, Tamil Nadu Amalgamated Unlisted Active Compliant
Share
Connect MCP
AO Apollo-Amrish Oncology Services Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Apollo Cbcc Cancer Care — 360° Intelligence Report

Generated from MCA filings & public records
46/100
Trust Score
Caution Indicated

Apollo Cbcc Cancer Care is assessed as Caution Indicated with a Trust Score of 46/100. Apollo Cbcc Cancer Care is a private limited indian non-government company incorporated in 2014, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 18 Aug 2026 from the latest processed filings. Apollo-Amrish Oncology Services Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Neutral
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
46/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
43/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
5/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
15/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Externally credit-rated (BBB).

Charges position: 0 open (-) · 2 satisfied (13.90 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Yes Bank Limited2 48.0 cr
Compliance Score: 43/100 Caution Indicated
  • Company status is "Amalgamated" - not Active.
  • Balance sheet slightly behind (Mar 2024).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
AMITABHA BANERJEE 01234567 Director 01/04/2018 6 yrs Approved
AKHILESWARAN KRISHNAN 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
1
Capital events
12 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Apollo Hospitals International Limited Joint Ventures 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 60 · Distress 15
Growth signals & trust indicators
Steady revenue growth: +38% over 4 year(s).
Operating for 12+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Negative net worth.
Adverse company status: Amalgamated.
Compliance score is weak (43/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence36/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 4 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment35/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view37/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
15 Mar 2024
Charge satisfied
Yes Bank Limited
03 Aug 2023
Director ceased
RAMESH BALASUBRAMANIAN
10 Oct 2022
Charge created
Yes Bank Limited - 2.00 cr
30 Sep 2015
Director ceased
PREM KUMAR MENON
Director ceased
AMITABHA BANERJEE
01 Aug 2015
Securities allotted
933000 Equity Shares Without Differential Rights - 93.30 Lakh raised
Securities allotted
933000 Equity Shares Without Differential Rights - 1.68 cr raised
07 Jul 2015
Securities allotted
933000 Equity Shares Without Differential Rights - 93.30 Lakh raised
Securities allotted
933000 Equity Shares Without Differential Rights - 1.68 cr raised
08 Jun 2015
Securities allotted
417000 Equity Shares Without Differential Rights - 41.70 Lakh raised
Securities allotted
417000 Equity Shares Without Differential Rights - 75.06 Lakh raised
07 May 2015
Securities allotted
417000 Equity Shares Without Differential Rights - 41.70 Lakh raised
Securities allotted
417000 Equity Shares Without Differential Rights - 75.06 Lakh raised
10

Key Observations

Auto-generated from the data above
Revenue grew 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
All 2 registered charge(s) stand satisfied - past borrowings repaid.
Carries an external credit rating of BBB from Crisil.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Capital has been raised through 12 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
King George Hospital U85300TG2018PTC127231 Khairatabad, Telangana, India
Ruby Ailcare Services Private Limited U85110PN2005PTC020949 Haveli, Maharashtra, India
Mediciti Health Care Services Private Limited U72200TS2003PTC174328 Khairatabad, Telangana, India
Alcon Victor Group U85110GA2000PTC002896 Panaji, Goa, India
Ihcs Technologies India Private Limited U72200GJ2012PTC085344 Vadodara, Gujarat, India
Onp Hospitals U85110MH1991PTC060891 Pune, Maharashtra, India
St.Mary'S Healthcare Private Limited U85100KL2012PTC031558 Thodupuzha, Kerala, India
Homeocare International U85193TG2009PTC065548 Secunderabad, Telangana, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Apollo Cbcc Cancer Care before audits and certifications: compliance score 43/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Apollo Cbcc Cancer Care: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 60/100, margin trends, ownership structure and peer set for Apollo Cbcc Cancer Care - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 46/100, distress signals and MSME payment-delay disclosures - know whether Apollo Cbcc Cancer Care pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Apollo Cbcc Cancer Care - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Apollo Cbcc Cancer Care an active company?

Apollo Cbcc Cancer Care has MCA status “Amalgamated” with a compliance score of 43/100 (Caution Indicated).

Is Apollo Cbcc Cancer Care financially healthy?

Apollo Cbcc Cancer Care has a Financial Health Score of 5/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Apollo Cbcc Cancer Care?

Its overall Trust Score is 46/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Apollo Cbcc Cancer Care?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Apollo Cbcc Cancer Care have loans or charges against its assets?

No open charges - all 2 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Apollo Cbcc Cancer Care up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 43/100 (Caution Indicated).

Is it risky to lend to Apollo Cbcc Cancer Care?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.